(login)
Leading pharmaceutical
company in the Baltic States
About «Grindeks»
Products
Services
Research & Development
For investors
For the media
Careers
Contacts
Print
Send
About «Grindeks»
«Grindeks» mission, vision and values
Governance and management
Structure
Shareholders
«Grindeks» worldwide
Europe
Asia
Africa
South America
North America
Central America
Australia and Oceania
All regions
EU projects
ERDF
Procurements
Notification about new procurement for reagents for analytical method development
Procurements archive
2011
Corporate Social Responsibility
Patient
Health promotion
Pharmacovigilance
Society
Student internship at the company
Tour of the company
Supporting growth of the industry specialists
Supporting sports and active lifestyle
Supporting culture
Employee
Occupational safety and health protection
Professional growth
Business environment
Honest and responsible communication
Ethics
Collaboration and partnership
Quality and environment protection
Quality and environmental management
Environment protection
Good Manufacturing Practice
«Grindeks» fund "For the Support of Science and Education"
Sponsorship and support projects
Supporting sports
Supporting culture
Supporting growth of the industry specialists
Health promotion
Sponsoring and support in previous years
History
1946-1956
1957-1971
1972-1984
1985-1990
1991-2006
2006-2012
Cooperation
«Grindeks» corporate film
«Grindeks» Road to achievements
Virtual tour of «Grindeks»
Products
Prescription medicine
Brand products
Mildronate®
Ftorafur®
List of all «Grindeks» products
Over-the-counter products
List of all «Grindeks» products
Active pharmaceutical ingredients
Products
Antazoline phosphate
Atipamezole hydrochloride
Detomidine hydrochloride
Desaminooxytocin
Dexmedetomidine hydrochloride (human)
Dexmedetomidine hydrochloride (veterinary)
Droperidol
Imatinib mesylate
Medetomodine hydrochloride
Milnacipran Hydrochloride
Oxytocin
Pemetrexed disodium
Rilmenidine dihydrogen phosphate
Solifenacin succinate
Tegafurum (Ftorafur)
Thioguanine
Ursodeoxycholic acid
Xylazine
Xylazine Hydrochloride
Zopiclone
Research and Development
Production
Sales
Product list
Services
Contacts
Sales agents
North America
South America
Middle East
References
Pharmacovigilance
Services
Research and Development
Research and Development of API
New Active Pharmaceutical Ingredients Analytical Scale-up Laboratory
Final dosage form development
Registration
Regulatory Strategy Planning
Regulatory Submissions and Support
Preparation, compilation of dossiers
Marketing Authorisation Applications consultancy and specific or full services
Regulatory Specialisation
Product information and Readability Test
Translations, proofreading and editing
Contract manufacturing
API manufacturing
cGMP Compliant operations
Premises and equipment
Final dosage forms manufacturing
Manufacturing
Packaging
Technology equipment
Topical form manufacturing
Production technology
Analytical services
Contacts
Research & Development
Research and Development of APIs
Preclinical trials
Clinical trials
For investors
Corporate governance
Structure of concern
Shareholders
Supervisory Council
Charter of the Council
Board
Charter of the Board
Audit Committee
Articles of association
Stock news
Archive
Information on security trading
Security trading history
Trading
Comparison of historical price with relevant index
IR Calendar 2013
Financial reports
Financial indicators
Resolutions of Shareholders' Meetings
Archive
Presentations on «Grindeks»
Contacts
Subscribe to news
For the media
Latest news
News archive
Publications
Gallery
Company logo
Supervisory Council
Company
Investment projects
Informative materials
Contacts
Subscribe to news
Careers
Personnel Policy
Contacts
Contacts
Branches
Representative Offices
Bank account specifications
Contact us
Home
Up
back